Explore the resources outlined below to gain further insights into EYLEA® 8mg (114.3 mg/ml aflibercept) in neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular oedema (DME).

Key steps for preparing and injecting OcuClick®
Below you will find the key steps that must be followed when preparing for intravitreal injection using OcuClick. Always consult the OcuClick instructions for use (IFU) card, which provides more detail for each step.
Flexible Dosing Options
Dosing regimens in nAMD and DME
Eylea® 8mg - Insurance Claim Codes
Contains codes for major Irish insurance organisations
PP-EYL_8mg-IE-0162-1 | December 2025
